Back
Purpose Global Flexible Crdt ETF NCH CAD Vs. Aligos Therapeutics Industry Stock Comparison
Buy
59
FLX.B.TO
Purpose Global Flexible Crdt ETF NCH CAD
Last Price:
$8.45
Seasonality Move:
1.88%
Buy
63
ALGS
Aligos Therapeutics
Last Price:
$8.42
Seasonality Move:
-13.29%
Buy
59
Purpose Global Flexible Crdt ETF NCH CAD (FLX.B.TO)
is a Buy
Is Purpose Global Flexible Crdt ETF NCH CAD a Buy, Sell or Hold?
-
The current Purpose Global Flexible Crdt ETF NCH CAD [FLX.B.TO] share price is $8.45. The Score for FLX.B.TO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
FLX.B.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $8.79. The Score for ALGS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FLX.B.TO Stock Price Chart
What is Purpose Global Flexible Crdt ETF NCH CAD's stock price today?
-
The Purpose Global Flexible Crdt ETF NCH CAD share price today is $8.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FLX.B.TO is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $8.79Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
FLX.B.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.59 | Buy |
Relative Strength Index (14 RSI): | 49.85 | Sell |
Chaikin Money Flow: | -1704 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.4 - 8.48) | Buy |
Bollinger Bands (100): | (8.35 - 8.81) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.44 | Buy |
Relative Strength Index (14 RSI): | 63.36 | Buy |
Chaikin Money Flow: | 32158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.95 - 8.21) | Buy |
Bollinger Bands (100): | (4.15 - 13.05) | Buy |
FLX.B.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.45 | Sell |
20-day SMA: | 8.45 | Buy |
50-day SMA: | 8.45 | Buy |
200-day SMA: | 8.73 | Sell |
8-day EMA: | 4.48 | Buy |
20-day EMA: | 2.19 | Buy |
50-day EMA: | 0.96 | Buy |
200-day EMA: | 0.25 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.87 | Buy |
20-day SMA: | 7.77 | Buy |
50-day SMA: | 6.53 | Buy |
200-day SMA: | 15.18 | Sell |
8-day EMA: | 8.08 | Buy |
20-day EMA: | 7.63 | Buy |
50-day EMA: | 7.59 | Buy |
200-day EMA: | 12.94 | Sell |
Purpose Global Flexible Crdt ETF NCH CAD Earnings Growth & FLX.B.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.07 per share, an increase this year of $3.67 per share, and a decrease next year of $1.69 per share.
Purpose Global Flexible Crdt ETF NCH CAD Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 2 | Jul 3 | Jul 4 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |